Akums Drugs and Pharma, Lyrus Life Sciences ink pact for development of patented technologies

New Delhi: Akums Drugs and Pharmaceuticals Limited has partnered with Lyrus Life Sciences for a number of patented technologies and formulations. 

According to the release, the unique treatments and therapies emerging from this collaboration will ensure the launch of patented drugs and more patient-friendly formulations that are beneficial for patients. The products and technologies are carefully selected to address the unmet need in the areas of pain, obesity, diabetes, psoriasis, seasonal flu, respiratory insufficiency, immunity, and women’s health with a special focus on the geriatric and pediatric population.

Managing Director of Akums, Sanjeev Jain shared that the partnership comes at a vital time in the company's journey when there is a need to launch differentiated formulations with global patents thus providing an edge. "Akums is always willing to integrate value-added quality and leverage partnerships with innovative R&D companies to better serve its clients and patients around the world. We are excited about this new partnership with Lyrus Life Sciences and exceedingly optimistic that this partnership will bring more innovative products to the medical fraternity. Akums' commitment is to continue to serve the domestic and international market that has received a boost from this collaboration." he said.

C.P. Bothra, Chairman of Lyrus Life Sciences Opined, " Lyrus with a vision to establish itself as a trusted partner of choice for innovative drug delivery solutions is equipped with a world-class Research & Development Infrastructure. Most noteworthy it has a strong team of qualified scientists and professionals with decades of success in the industry and has more than 20 patents filed worldwide. We’re glad to join hands with Akums which has proven itself over the years as a truly reliable brand and a manufacturing powerhouse. This agreement is a win-win for both, as combined expertise, technologies, and innovation will be beneficial to both patients and doctors as well."

Read also: Akums Drugs and Pharma bags DCGI nod to unveil type 2 diabetes drug Lobeglitazone in India